2012
DOI: 10.1002/jbmr.1702
|View full text |Cite
|
Sign up to set email alerts
|

Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss

Abstract: Osteoporosis is characterized by enhanced differentiation of bone-resorbing osteoclasts, resulting in a rapid loss of functional trabecular bone. Bone-forming osteoblasts and osteoblast-derived osteocytes perform a key role in the regulation of osteoclast development by providing both the pro-osteoclastogenic cytokine receptor activator of NF-kB ligand (RANKL) and its natural decoy receptor osteoprotegerin (OPG). By regulating the RANKL/OPG ratio, osteoblasts hence determine the rate of both osteoclast differe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
36
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 36 publications
(41 citation statements)
references
References 23 publications
4
36
0
Order By: Relevance
“…Modulation of inflammatory signaling by LXRs substantiates its use as a therapeutic target for inflammatory diseases. With respect to pathological bone disease, activation of LXRs has been demonstrated to play a protective role in the prevention of rheumatoid arthritis [30], osteoarthritis [31], [32], and postmenopausal osteoporosis [33]. In the past years, there have been several experiments focusing on the association between LXRA and/or LXRB gene polymorphisms with different diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Modulation of inflammatory signaling by LXRs substantiates its use as a therapeutic target for inflammatory diseases. With respect to pathological bone disease, activation of LXRs has been demonstrated to play a protective role in the prevention of rheumatoid arthritis [30], osteoarthritis [31], [32], and postmenopausal osteoporosis [33]. In the past years, there have been several experiments focusing on the association between LXRA and/or LXRB gene polymorphisms with different diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Since full activation of the SREBP1 promoter requires participation by LXR, we speculate that bone osteocytes secrete a lipid-like activator of LXR. 46,66 Osteocytes are known to produce oxysterols which could bind to and activate the LXR receptor. Alternatively, as noted above, PPAR-g receptor regulates several aspects of muscle regeneration following exercise.…”
Section: Dec1 and Dec2 Are Subject To Regulation By Circadian Core Prmentioning
confidence: 99%
“…Remen et al (108) show that LXR activation by GW3965 significantly inhibits osteoclast differentiation and bone resorption in an LXR␤-dependent manner, potentially via suppressing the NFATc1/p38/microophthalmia-associated transcription factor axis. Kleyer et al (109) show that LXR agonists can protect female mice from OVX-induced bone loss by decreasing the RANKL to OPG ratio. Similarly, two reports in 2013 show that LXR agonists can attenuate lipopolysaccharide-induced osteoclast differentiation by suppressing the activity of NFB and c-fos to reduce the expression of osteoclast markers Acp5, Ctsk, Mmp-9, dendritic cell-specific transmembrane protein, and Itg␤3 (110,111).…”
Section: Liver X Receptor (Lxr)mentioning
confidence: 99%